MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression

Long Noncoding RNAs (LncRNAs) have recently been identified as key regulator in tumor progression. The LncRNA MAFG-AS1 has been reported to facilitate the progression of multiple cancers, however, its role in prostate cancer is still unknown. Here, we reported that MAFG-AS1 was upregulated in prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peizhang, Shi, Yuanping, Guo, Miaomiao, Xu, Huan, Zhan, Ming, Wang, Zhong, Chen, Yanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389335/
https://www.ncbi.nlm.nih.gov/pubmed/35992831
http://dx.doi.org/10.3389/fonc.2022.856580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389335/
https://www.ncbi.nlm.nih.gov/pubmed/35992831
http://dx.doi.org/10.3389/fonc.2022.856580

Ejemplares similares